| Alias |
4-Amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione;3-Amino-N-(2,6-dioxo-3-piperidyl)phthalimide;4-Amino-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione;Pomalidomide;4-amino-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione;Pomalidomide-D4;1H-?Isoindole-?1,?3(2H)?-?dione, 4-?amino-?2-?(2,?6-?dioxo-?3-?piperidinyl)?-;CC4047;CC-4047;1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline;3-amino-N-(2,6-dioxo-3-piperidyl)phthalamide;Actimid;IMiD 3;Actimid (Celgene);Pomalidomide(CC-4047);pomalidomide,Pomalyst;Pomalidomide(CC-4047,Actimid);PoMalyst iMpurity;Pomalyst;Imnovid;4-Aminothalidomide;CC 4047;1H-Isoindole-1,3(2H)-dione, 4-amino-2-(2,6-dioxo-3-piperidinyl)-;IMID-3;AK104087;4-amino-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione;4-amino-2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione;4-amino-2-(2,6-dioxo-3-pi;Pomalidomide, >=99%;Q7227206;Q7227206;CHEMBL43452;CHEMBL43452;Pomalidomide (JAN/USAN/INN);Pomalidomide (JAN/USAN/INN);Pomalyst (TN);Pomalyst (TN);DA-21486;DA-21486;CHEBI:72690;CHEBI:72690;CFC83849;CFC83849;3-aminio-phthalimido-glutarimide;3-aminio-phthalimido-glutarimide;443919-33-3;443919-33-3;HY-10984;HY-10984;Pomalidomide, >=98% (HPLC);Pomalidomide, >=98% (HPLC);DTXSID40893458;DTXSID40893458;BP164278;BP164278;4-amino-2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione;4-amino-2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione;4-Amino-2-((3RS)-2,6-dioxopiperidin-3-yl)-2H-isoindole-1,3-dione;4-Amino-2-((3RS)-2,6-dioxopiperidin-3-yl)-2H-isoindole-1,3-dione;BCP02890;BCP02890;3-(3-AMINO)-PHTALAMIDO-GLUTARIMIDE;3-(3-AMINO)-PHTALAMIDO-GLUTARIMIDE;BRD-A12994259-001-02-1;BRD-A12994259-001-02-1;POMALIDOMIDE [VANDF];POMALIDOMIDE [VANDF];POMALIDOMIDE [ORANGE BOOK];POMALIDOMIDE [ORANGE BOOK];P2074;P2074;HMS3744K07;HMS3744K07;BCP0726000263;BCP0726000263;pomalidomidum;pomalidomidum;DB08910;DB08910;IMiD1;IMiD1;19171-19-8;19171-19-8;Phthalimide, 3-amino-N-(2,6-dioxo-3-piperidyl)-;Phthalimide, 3-amino-N-(2,6-dioxo-3-piperidyl)-;BCP09107;BCP09107;UVSMNLNDYGZFPF-UHFFFAOYSA-N;SR-01000941573;UVSMNLNDYGZFPF-UHFFFAOYSA-N;4-Amino-2-(2,6-dioxo-3-piperidinyl)isoindole-1,3-dione;SR-01000941573;Pomalidomida;4-Amino-2-(2,6-dioxo-3-piperidinyl)isoindole-1,3-dione;Pomalidomida;4-Amino-2-[(3RS)-2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione;4-Amino-2-[(3RS)-2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione;CDC-394;4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione;POMALIDOMIDE [EMA EPAR];CDC-394;AKOS013400288;4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione;3-Aminophthalimidoglutarimide;POMALIDOMIDE [EMA EPAR];NSC-775351;AKOS013400288;GTPL7348;3-Aminophthalimidoglutarimide;C13H11N3O4;NSC-775351;SR-01000941573-1;GTPL7348;MLS006011261;C13H11N3O4;CCG-264684;SR-01000941573-1;4-amino-2-(2,6-dioxo(3-piperidyl))isoindoline-1,3-dione;MLS006011261;NSC-767909;CCG-264684;CS-0165;4-amino-2-(2,6-dioxo(3-pi... |
